Black Rock Inc. Celularity Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.81 $1.09 Million - $2.11 Million	-2,600,888 Reduced 77.13%	771,410 $408,000
Q1 2023 May 12, 2023	SELL	$0.56 - $1.15 $132,401 - $271,896	-236,432 Reduced 6.55%	3,372,298 $2.09 Million
Q4 2022 Feb 13, 2023	BUY	$1.08 - $2.35 $148,603 - $323,350	137,596 Added 3.96%	3,608,730 $4.66 Million
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $1.16 Million - $11.6 Million	2,686,262 Added 342.25%	3,471,134 $8.02 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $2.13 Million - $9.81 Million	759,567 Added 3001.65%	784,872 $2.67 Million
Q3 2021 Nov 09, 2021	BUY	$6.05 - $12.15 $153,095 - $307,455	25,305 New	25,305 $179,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.